BIOINVENT INTERNATIONAL AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.95 SEK | +2.28% |
|
+7.16% | +42.14% |
| 04-30 | BioInvent Announces Evaluating Attana Technology | CI |
| 04-24 | BioInvent International AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on BioInvent International AB
Price target over the last 5 years
History of analyst recommendation changes
33d0df1bceb85c.DcD576mp63hQbjkKCKRrTNABIn04TtsbB3AS-pW5Y7g.X7a8q82Eo0gDMWljZZE9NIBAEDZzH4wvMQFliaz6IcJaqKmg7OHTQX00bA~eea52070ca9c4a9924894528eee43a8e
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
26.95
SEK
Average target price
83
SEK
Spread / Average Target
+207.98%
High Price Target
83
SEK
Spread / Highest target
+207.98%
Low Price Target
83
SEK
Spread / Lowest Target
+207.98%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
- Stock Market
- Equities
- BINV Stock
- Consensus BioInvent International AB
